A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HBs / hepatitis B surface

[Related PubMed/MEDLINE]
Total Number of Papers: 72
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HBs  (>> Co-occurring Abbreviation)
Long Form:   hepatitis B surface
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein. HBc, HBV
2016 Effect of Tetanus-diphtheria Vaccine on Immune Response to Hepatitis B Vaccine in Low-responder Individuals. HBsAb, HBV, Td
2016 Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France. CHB, TDF
2016 Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine. GMC, HBV
2015 HBV carrying drug-resistance mutations in chronically infected treatment-naive patients. CHB, NA, RT
2015 Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice. CTLA4Ig, CTLs, HBV, PBMCs
2015 Scavenging of hydroxyl radicals generated in human plasma following X-ray irradiation. ESR
2014 Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines: randomized, double-blind study in malaria-naive adults. AEs, CS, GMTs
2013 Occupational exposure to blood and body fluids among healthcare workers in a teaching hospital: an experience from northern Thailand. HBV, HCWs
10  2012 Epidemiological and virological characteristics of symptomatic acute hepatitis E in Greater Cairo, Egypt. HAV, HBc, HEV, ULN
11  2011 Chronic hepatitis C virus infection is associated with more severe asthma. HCV
12  2011 Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration. DL-1-MT, IDO
13  2010 Positivity of HIV, hepatitis B and hepatitis C in patients enrolled in a confidential self-exclusion system of blood donation: a cross-sectional analytical study. CSE, HCV, HIV
14  2009 Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran, 2002. HBV, HCV, HIV, RPR
15  2008 Hepatic granuloma in Turkish adults: a report of 13 cases. CT, HCV, HG, VDRL
16  2008 High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers. HBc, HBV, MIR, MPyV, VLP
17  2007 Development of gene vectors for pinpoint targeting to human hepatocytes by cationically modified polymer complexes. DMAEMA, NPMA
18  2007 Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity. HBV, PCR
19  2006 Antigen-specific central memory CD4+ T lymphocytes produce multiple cytokines and proliferate in vivo in humans. ---
20  2006 Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif. HBV, RT
21  2005 Full genomic analysis of hepatitis delta virus prevalent on Miyako Island, Japan. HDV, PCR
22  2005 Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. VZV
23  2004 Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus. AFP, HBe, HBV, HCC, HCV, HGV, MMP
24  2004 Matrix effects in clinical immunoassays and the effect of preheating and cooling analytical samples. HCV, IgG, RF
25  2003 Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation. CML, HBV, HCT
26  2002 Limited lamivudine and long-term hepatitis B immunoglobulin immunoprophylaxis for prevention of hepatitis B recurrence after liver transplantation. HBV, LT
27  2001 Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia. Ab, B-CLL, ELISA, EMC, MM, RA, RIBA
28  2001 Nucleotide sequence of the precore/core gene and X gene of hepatitis B virus DNA in asymptomatic hepatitis B virus carriers who are negative for serum hepatitis B core antibody. HBc, HBV, HBV2, nt, ORFs, PCR
29  2001 Prevalence of human immunodeficiency virus, hepatitis B and hepatitis C virus antibodies and hepatitis B antigen among commercial sex workers in Japan. CSW, HBV, HCV, HIV, STD
30  2000 Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance. HBc, HBV
31  2000 [Hepatitis B virus gene mutations in the sera of three patients with coexisting hepatitis B surface antigen and anti-surface antibody]. C/EBP
32  1999 Major compared with limited hepatic resection for hepatocellular carcinoma without underlying cirrhosis: a retrospective analysis. HCC
33  1997 Acute exacerbation of hepatitis due to reactivation of hepatitis B virus with mutations in the core region after chemotherapy for malignant lymphoma. ---
34  1997 Differential localization of s and e antigens in hepatitis B virus-associated glomerulonephritis. HB, HBc, HBe
35  1996 Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line. HBV
36  1996 Recurrent demyelinating transverse myelitis in a high titer HBs-antigen carrier. CNS, MBP
37  1996 Serial changes in titers of antibody to hepatitis B surface antigen after immunization of infants born to mothers with hepatitis B e antigen. HB, HBe, HBV
38  1995 Study of hepatic functions and prevalence of hepatitis-B surface antigenaemia in Omani children with sickle cell disease. ALT, SCD
39  1995 [Investigation on change of acquired antibodies in responders against hepatitis B vaccine]. C.I, RIA
40  1994 Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia. HCC, LCD
41  1993 Diagnostic markers of viral hepatitis B and C. HBc, HBe, HBV, HCV
42  1993 Hepatocellular carcinoma and its risk factors--their annual changes and effects on the age at onset. HBV, HCC
43  1993 Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences. ---
44  1992 Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis. HBV, HCV, NANBH, PCR
45  1990 Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts. HBV, SV40
46  1990 Intradermal hepatitis B vaccination in thalassaemia. ---
47  1990 Study on some hepatic functions and prevalence of hepatitis B surface antigenaemia in Egyptian children with schistosomal hepatic fibrosis. ALT, SHF
48  1989 A study on the properties of commercial thrombin preparations. HIV
49  1988 Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. HBcAg, HBsAg, HBV
50  1988 [Virologic considerations in donor selection for allogeneic keratoplasty]. HIV
51  1987 Cell type specific expression of pre S 1 antigen and secretion of hepatitis B virus surface antigen. Brief Report. ---
52  1987 Interaction of hepatitis B surface antigen with serum albumin of various species on polystylene latex particles. HBe
53  1986 Glomerulonephritis associated with hepatitis B surface antigenemia. Report of a case with features of both membranous and IgA nephropathy. ---
54  1986 Production of stable mouse x human hybridomas secreting HBs antigen-specific human monoclonal antibody by using in vitro sensitization. PBMs
55  1985 Culturing of human hepatocellular carcinoma. A simple and reproducible method. HHC
56  1985 Stable HBV surface antigen expression by Vero cell clones after transfection. ---
57  1985 [Pediatric papular acrodermatitis and double primary infection by the hepatitis B virus and the Epstein-Barr virus]. ---
58  1983 Association of hepatitis B surface (HBs) antigenemia and membranous nephropathy in children in Taiwan. HBsAg, HBV, MN
59  1983 Hepatitis B virus associated membranous glomerulonephritis. HBsAg, HBV
60  1983 Studies on the in vitro antigenicity test of the hepatitis B surface antigen preparation and its relationship to the in vivo potency estimate. HB
61  1982 Hepatitis B virus antigens in liver tissue in hepatocellular carcinoma and advanced chronic liver disease-relationship to liver cell dysplasia. Ag
62  1981 Hepatitis B and the dialysis and renal transplantation unit. HBsAg
63  1981 Hepatitis B infection in hospital personnel during an eight-year period; policies for screening and pregnancy in high risk areas. HBsAg
64  1980 A 6-year-old boy having hepatocellular carcinoma associated with hepatitis B surface antigenemia. HBV
65  1980 Non-a, non-b hepatitis: identification of hepatitis-B-like virus particles in serum and liver. Ag
66  1980 Viral antibody titres in HBs antigen-positive and -negative chronic active hepatitis. ---
67  1979 Discrimination of Antibodies to Hepatitis B surface antigen from antibodies to inherited serum protein variants in immune sera of human and animal origin. ---
68  1977 Clincial and edidemiological studies on hepatitis B in children. anti-HBs
69  1977 Detection of hepatitis B antigen in circulating immune complexes in acute and chronic hepatitis. ---
70  1977 [Immunofluorescence of hepatitis b surface (HBs) antigen in conventionally paraffin-embedded liver biopsy material (author's transl)]. ---
71  1976 Platelet aggregation by hepatitis B surface antigen-antibody complexes. ---
72  1975 Direct solid-phase radioimmunoassay (dSP-RIA) for detection of antibody to hepatitis B surface (HBs) antigen. dSP-RIA